• Je něco špatně v tomto záznamu ?

Histology-Stratified Tumor Control and Patient Survival After Stereotactic Radiosurgery for Pineal Region Tumors: A Report From the International Gamma Knife Research Foundation

C. Iorio-Morin, H. Kano, M. Huang, LD. Lunsford, G. Simonová, R. Liscak, O. Cohen-Inbar, J. Sheehan, CC. Lee, HM. Wu, D. Mathieu,

. 2017 ; 107 (-) : 974-982. [pub] 20170724

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016467

BACKGROUND: Pineal region tumors represent a rare and histologically diverse group of lesions. Few studies are available to guide management and the outcomes after stereotactic radiosurgery (SRS). METHODS: Patients who underwent SRS for a pineal region tumor and for whom at least 6 months of imaging follow-up was available were retrospectively assessed in 5 centers. Data were collected from the medical record and histology level analyses were performed, including actuarial tumor control and survival analyses. RESULTS: A total of 70 patients were treated between 1989 and 2014 with a median follow-up of 47 months. Diagnoses were pineocytoma (37%), pineoblastoma (19%), pineal parenchymal tumor of intermediate differentiation (10%), papillary tumor of the pineal region (9%), germinoma (7%), teratoma (3%), embryonal carcinoma (1%), and unknown (14%). Median prescription dose was 15 Gy at the 50% isodose line. Actuarial local control and survival rates were 81% and 76% at 20 years for pineocytoma, 50% and 56% at 5 years for pineal parenchymal tumor of intermediate differentiation, 27% and 48% at 5 years for pineoblastoma, 33% and 100% at 5 years for papillary tumor of the pineal region, 80% and 80% at 20 years for germinoma, and 61% and 67% at 5 years for tumors of unknown histology. New focal neurological deficit, Parinaud syndrome, and hydrocephalus occurred in 9%, 7%, and 3% of cases, respectively. CONCLUSIONS: SRS is a safe modality for the management of pineal region tumors. Its specific role is highly dependent on tumor histology. As such, all efforts should be made to obtain a reliable histologic diagnosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016467
003      
CZ-PrNML
005      
20180523093424.0
007      
ta
008      
180515s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.wneu.2017.07.097 $2 doi
035    __
$a (PubMed)28751141
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Iorio-Morin, Christian $u Division of Neurosurgery, Department of Surgery, Université de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
245    10
$a Histology-Stratified Tumor Control and Patient Survival After Stereotactic Radiosurgery for Pineal Region Tumors: A Report From the International Gamma Knife Research Foundation / $c C. Iorio-Morin, H. Kano, M. Huang, LD. Lunsford, G. Simonová, R. Liscak, O. Cohen-Inbar, J. Sheehan, CC. Lee, HM. Wu, D. Mathieu,
520    9_
$a BACKGROUND: Pineal region tumors represent a rare and histologically diverse group of lesions. Few studies are available to guide management and the outcomes after stereotactic radiosurgery (SRS). METHODS: Patients who underwent SRS for a pineal region tumor and for whom at least 6 months of imaging follow-up was available were retrospectively assessed in 5 centers. Data were collected from the medical record and histology level analyses were performed, including actuarial tumor control and survival analyses. RESULTS: A total of 70 patients were treated between 1989 and 2014 with a median follow-up of 47 months. Diagnoses were pineocytoma (37%), pineoblastoma (19%), pineal parenchymal tumor of intermediate differentiation (10%), papillary tumor of the pineal region (9%), germinoma (7%), teratoma (3%), embryonal carcinoma (1%), and unknown (14%). Median prescription dose was 15 Gy at the 50% isodose line. Actuarial local control and survival rates were 81% and 76% at 20 years for pineocytoma, 50% and 56% at 5 years for pineal parenchymal tumor of intermediate differentiation, 27% and 48% at 5 years for pineoblastoma, 33% and 100% at 5 years for papillary tumor of the pineal region, 80% and 80% at 20 years for germinoma, and 61% and 67% at 5 years for tumors of unknown histology. New focal neurological deficit, Parinaud syndrome, and hydrocephalus occurred in 9%, 7%, and 3% of cases, respectively. CONCLUSIONS: SRS is a safe modality for the management of pineal region tumors. Its specific role is highly dependent on tumor histology. As such, all efforts should be made to obtain a reliable histologic diagnosis.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nádory mozku $x mortalita $x patologie $x chirurgie $7 D001932
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    12
$a internacionalita $7 D038622
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a lokální recidiva nádoru $x mortalita $x patologie $x chirurgie $7 D009364
650    _2
$a epifýza mozková $x patologie $x chirurgie $7 D010870
650    _2
$a pinealom $x mortalita $x patologie $x chirurgie $7 D010871
650    _2
$a radiochirurgie $x mortalita $x trendy $7 D016634
650    _2
$a výzkumná zpráva $7 D058028
650    _2
$a míra přežití $x trendy $7 D015996
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Kano, Hideyuki $u Department of Neurological Surgery Center for Image-Guided Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
700    1_
$a Huang, Marshall $u Department of Neurological Surgery Center for Image-Guided Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
700    1_
$a Lunsford, L Dade $u Department of Neurological Surgery Center for Image-Guided Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
700    1_
$a Simonová, Gabriela $u Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Liscak, Roman $u Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Cohen-Inbar, Or $u Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
700    1_
$a Sheehan, Jason $u Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
700    1_
$a Lee, Cheng-Chia $u Taipei Veterans General Hospital Neurological Institute, Taipei, Taiwan.
700    1_
$a Wu, Hsiu-Mei $u Taipei Veterans General Hospital Neurological Institute, Taipei, Taiwan.
700    1_
$a Mathieu, David $u Division of Neurosurgery, Department of Surgery, Université de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: david.mathieu@usherbrooke.ca.
773    0_
$w MED00167613 $t World neurosurgery $x 1878-8769 $g Roč. 107, č. - (2017), s. 974-982
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28751141 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180523093609 $b ABA008
999    __
$a ok $b bmc $g 1300091 $s 1013307
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 107 $c - $d 974-982 $e 20170724 $i 1878-8769 $m World neurosurgery $n World Neurosurg $x MED00167613
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Možnosti archivace